Evidence map›Paper›PMID 21792347›Full record

ArticleCrystal growth & design2011

Developing a Fluorescence-based Approach to Screening for Macromolecule Crystallization Conditions.

Marc L Pusey

Abstract read
In one paragraph

Article in Crystal growth & design, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Microseed matrix screening for optimization in protein crystallization: what have we learned?Acta crystallographica. Section F, Structural biology communications · 2014
    Article
  4. Introduction to protein crystallization.Acta crystallographica. Section F, Structural biology communications · 2014
    Review
  5. Some practical guidelines for UV imaging in the protein crystallization laboratory.Acta crystallographica. Section F, Structural biology and crystallization communications · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Marc L PuseyiXpressGenes, Inc. 601 Genome Way Huntsville, AL 35806.
iXpressGenes (United States) · US

Funding

Fluorescence Anisotropy-based Macromolecule Crystallization ScreeningR44GM084488 · NIGMS · IXPRESSGENES, INC. · PI PUSEY, MARC LEE · 2010 to 2011
$744k
Fluorescence Anisotropy-based Macromolecule Crystallization ScreeningR43GM084488 · NIGMS · IXPRESSGENES, INC. · PI PUSEY, MARC LEE · 2008 to 2008
$100k
NIGMS NIH HHS R43 GM084488NIGMS NIH HHS R44 GM084488
6 · The paper itself

Abstract

Current macromolecule crystallization screening methods rely on the random testing of crystallization conditions, in the hope that one or more will yield positive results, crystals. Most plate outcomes are either clear or precipitated solutions, which results are routinely discarded by the experimenter. However, many of these may in fact be close to crystallization conditions, which fact is obscured by the nature of the apparent outcome. We are developing a fluorescence-based approach to the determination of crystallization conditions, which approach can also be used to assess conditions that may be close to those that would give crystals. The method uses measurements of fluorescence anisotropy and intensity. The method was first tested using model proteins, with likely outcomes as determined by fluorescence measurements where the plate data showed either clear or precipitated solutions being subjected to optimization screening. The results showed a ~83% increase in the number of crystallization conditions. The method was then tried as the sole screening method with a number of test proteins. In every case at least one or more crystallization conditions were found, and it is estimated that ~53% of these would not have been found using a plate screen.

Identifiers

PMID21792347
PMCPMC3142472
OpenAlexW2334936010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.